 Shares of Alterity Therapeutics Ltd NASDAQ: ATHE gap-opened Mondays session higher and are sustaining the gains. What Happened: The Australian biopharma said the U.S. Patent and Trademark Office has approved a new composition of matter patent related to its drug development portfolio focused on neurodegenerative diseases. 